← Lobby register
Disclosed budget
€50,000 — €99,999
Meetings 12mo
0
Policy files
0
Accredited passes
0
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 15 Mar 2025 | Axel Hellman Cabinet member | Impact of EU environmental policies on the life science sector | — |
| 15 Mar 2025 | Axel Hellman Cabinet member | Impact of EU environmental policies on the life science sector | SRC |
| 11 Feb 2025 | Rainer Becker Director | Exchange of views on EU policies in the areas of life science and biotechnology | — |
| 11 Feb 2025 | Giulia Del Brenna Head of Unit | The current state of the EU pharmaceutical sector, ways to strengthen EU competitiveness, the forthcoming Life Sciences Strategy and Biotech Act | SRC |
| 11 Feb 2025 | Rainer Becker Director | Exchange of views on EU policies in the areas of life science and biotechnology | SRC |
| 11 Feb 2025 | Giulia Del Brenna Head of Unit | The current state of the EU pharmaceutical sector, ways to strengthen EU competitiveness, the forthcoming Life Sciences Strategy and Biotech Act | — |
| 15 Feb 2018 | Kaius Kristian Hedberg Cabinet member | pharmaceutical IP incentives | — |
| 15 Feb 2018 | Kaius Kristian Hedberg Cabinet member | pharmaceutical IP incentives | SRC |
Mission & Goals
Lif är branschorganisationen för de forskande läkemedelsföretagen i Sverige. Vi arbetar för en högkvalitativ vård och tillgång till nya behandlingar genom att stärka den svenska life science-sektorn i samverkan med vårdens aktörer, politiker, tjänstemän och patientföreträdare.
EU Legislative Interests
Biotech Act EU Life sciences strategy REACH UWWTD EU Pharma legislation EU Patent Package EHDS AI ACT EU Pharmaceutical Incentives Analysis. EU HTA Regulation IHI AMR Pharmacueticals in the environment (PiE)
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Svenskt Näringsliv EFPIA AESGP IMM (institutet mot mutor) IFPMA EUCOPE
Organisation Members
Läkemedelsföretag